| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/10/2008 | CA2654837A1 Process for the preparation of sterically hindered nitroxyl ethers |
| 01/09/2008 | EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives |
| 01/09/2008 | EP1874746A2 Novel histamine h3-receptor ligands and their therapeutic applications |
| 01/09/2008 | EP1874730A1 Substituted butyrophenone derivatives |
| 01/09/2008 | EP1874727A1 New muscarinic receptor antagonists |
| 01/09/2008 | EP1527048B1 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | CN101103002A 3,4,(5)-substituted tetrahydropyridines |
| 01/09/2008 | CN101100453A Method for synthesizing ifenprodil tartrate |
| 01/08/2008 | US7317104 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
| 01/08/2008 | US7317103 Imaging agents for diagnosis of Parkinson's disease |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317025 Non-peptidic NPY Y2 receptor inhibitors |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/03/2008 | WO2008002820A2 Substituted benzyl amine compounds |
| 01/03/2008 | WO2008002817A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | WO2008000131A1 α-AMINO-N-SUBSTITUTED AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF |
| 01/03/2008 | WO2007119118A3 Synthesis and preparations of intermediates and polymorphs thereof useful for the preparation of donepezil hydrochloride |
| 01/03/2008 | WO2007049303A3 An improved process for the preparation of highly pure fexofenadine |
| 01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof |
| 01/03/2008 | US20080004314 Phenylpiperidines and Phenylpyrrolidines |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080004263 Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof |
| 01/03/2008 | US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death |
| 01/03/2008 | US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors |
| 01/03/2008 | CA2656089A1 Substituted benzyl amine compounds |
| 01/03/2008 | CA2656075A1 Butyl and butynyl benzyl amine compounds |
| 01/02/2008 | EP1871743A1 Antiparasitic compounds |
| 01/02/2008 | EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 01/02/2008 | EP1871379A2 Cyanoarylamines |
| 01/02/2008 | EP1644334B1 Antithrombotic ethers |
| 01/02/2008 | EP1458743B1 Tetrahydrobenzfluorene derivatives |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1210082B1 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
| 01/01/2008 | US7314875 Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 12/27/2007 | WO2007149929A1 Piperidine derivatives for the treatment of gastrointestinal and cns disorders |
| 12/27/2007 | WO2007149508A2 Non-competitive nmda receptor antagonists |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148208A2 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 12/27/2007 | WO2007147770A2 Substituted phenyl methanone derivatives |
| 12/27/2007 | WO2007147604A2 Aqueous, alkaline bath, devoid of cyanide, for depositing electroplated zinc alloy coatings |
| 12/27/2007 | WO2007147603A2 Aqueous alkaline bath, devoid of cyanide, for the deposition of electroplated zinc and zinc alloy coatings |
| 12/27/2007 | WO2007130821A3 Mglur5 modulators ii |
| 12/27/2007 | WO2007117559A8 Renin inhibitors |
| 12/27/2007 | WO2007092558A3 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 12/27/2007 | WO2007092435A3 11-beta hsd1 inhibitors |
| 12/27/2007 | WO2007064914A3 5-(arylsulfonyl)-pyrazolopiperidines |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299114 Biaryl Derivatives |
| 12/27/2007 | US20070299110 Novel Tetrazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate |
| 12/27/2007 | US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070299081 Heterocyclic Derivatives and Their Use as Mediators of Stearoyl-Coa Desaturase |
| 12/27/2007 | US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/27/2007 | US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/27/2007 | US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 12/27/2007 | CA2655654A1 New carbonylated (aza)cyclohexanes as dopamine d3 receptor ligands |
| 12/27/2007 | CA2653355A1 Substituted phenyl methanone derivatives |
| 12/26/2007 | EP1870495A1 Aqueous alkaline, cyanide-free, bath for the galvanic deposition of Zinc and Zinc alloy layers |
| 12/26/2007 | EP1870405A1 Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| 12/26/2007 | EP1870396A1 Benzyloxypropylamine derivative |
| 12/26/2007 | EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 12/26/2007 | EP1868998A2 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 12/26/2007 | EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 12/26/2007 | EP1868996A1 A process for the preparation of alpha-aryl-alpha-piperid-2-yl-acetamides and the acid hydrolysis thereof |
| 12/26/2007 | EP1868607A2 Isoqunoline compounds and methods of use thereof |
| 12/26/2007 | EP1868605A2 Phenyl and pyridyl lta4h modulators |
| 12/26/2007 | EP1491531B1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| 12/26/2007 | CN101094848A Organic compounds |
| 12/26/2007 | CN101094834A Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| 12/26/2007 | CN101092390A Method for preparing standard of nisoldipine |
| 12/26/2007 | CN101092384A A category of compound of alpha ¿C amido - N ¿C substituent amide, its composition, and application |
| 12/26/2007 | CN100357291C Method for synthesizing olefin type imidacloprid from imidacloprid by microorganism transformation |
| 12/26/2007 | CN100357258C Production of keto acids |
| 12/25/2007 | US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof |
| 12/25/2007 | US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically |
| 12/25/2007 | US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 12/25/2007 | US7312332 Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products |
| 12/25/2007 | US7312235 Anticoagulants |
| 12/25/2007 | US7312233 4-(2,2-dichlorocyclopropyl)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's disease, Alzheimer's disease, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 12/25/2007 | US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 12/21/2007 | WO2007144639A1 2 -oxybenzamide derivatives as parp inhibitors |
| 12/21/2007 | WO2007144400A1 Benzylpiperazine derivatives as motilin receptor antagonists |
| 12/21/2007 | WO2007144394A2 Pharmaceutical use of substituted piperidine carboxamides |
| 12/21/2007 | WO2007144391A1 Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation |